These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7590009)

  • 21. [Safety of proton pump inhibitors for long-term application].
    Kuipers E
    Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
    [No Abstract]   [Full Text] [Related]  

  • 22. Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole.
    Bortolotti M; Gentilini L; Morselli C; Giovannini M
    Dig Liver Dis; 2006 Feb; 38(2):78-81. PubMed ID: 16256447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of long-term omeprazole treatment.
    Pashankar DS
    Gastroenterology; 2000 Oct; 119(4):1177-8. PubMed ID: 11203032
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune haemolytic anaemia associated with use of omeprazole.
    Butt MI; Sajid S; Sobolewski S
    Br J Hosp Med (Lond); 2007 Feb; 68(2):108. PubMed ID: 17370722
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term use of proton pump inhibitors: are they really safe? A case of delayed acute interstitial nephritis.
    Krishnamurthy M; Snyder R; Bachurina M
    J Am Geriatr Soc; 2009 Aug; 57(8):1513-4. PubMed ID: 19682153
    [No Abstract]   [Full Text] [Related]  

  • 26. The ambulatory pH study is normal, but the patient is not--the importance of the symptoms index.
    Katz P
    Am J Gastroenterol; 1998 Jan; 93(1):129-31. PubMed ID: 9448198
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal omeprazole in the treatment of reflux pain in esophageal cancer.
    Zylicz Z; van Sorge AA; Yska JP
    J Pain Symptom Manage; 1998 Mar; 15(3):144-5. PubMed ID: 9564112
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 30. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
    Levin TR; Sperling RM; McQuaid KR
    Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

  • 32. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
    Bishop J; Furman M; Thomson M
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.
    Tepes B; Stabuc B; Kocijancic B; Ivanusa M
    Hepatogastroenterology; 2009; 56(89):67-74. PubMed ID: 19453031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
    Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
    Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 37. Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Bloemena EC; Sandell M; Nelis GF; Snel P; Festen HP; Meuwissen SG
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1343-6. PubMed ID: 10540050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurements and comparisons of lower esophageal sphincter pressures and serum gastrin levels in patients with gastroesophageal reflux.
    Farrell RL; Castell DO; McGuigan JE
    Gastroenterology; 1974 Sep; 67(3):415-22. PubMed ID: 4853121
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
    Neal K; Logan R
    Aliment Pharmacol Ther; 2001 Jul; 15(7):1085-6. PubMed ID: 11421886
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypergastrinaemia with long-term omeprazole treatment.
    Bateson MC
    Aliment Pharmacol Ther; 1999 Mar; 13(3):440-1. PubMed ID: 10103171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.